In consultation: Guidance and quality standards
Showing 1 to 10 of 12
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| NICE Funding Variation Request Consultation | Methods / process manual consultation | NICE process and methods | |
| Ianalumab for treating active Sjogren's syndrome ID6634 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Nirogacestat for treating desmoid tumours [ID6453] | Draft guidance | Technology appraisal guidance | |
| Modular update to NICE manuals: EQ-5D-5L value set | NICE general consultation | NICE general | |
| Prostate cancer: diagnosis and management (update) | Scoping | NICE guideline | |
| Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6757] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627] | Draft guidance | Technology appraisal guidance | |
| Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457] | Draft guidance | Technology appraisal guidance | |
| Oveporexton for treating type 1 narcolepsy [ID6622] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Ruxolitinib for treating moderate atopic dermatitis ID6602 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |